Timing 17 November 2022
Ceres Power Holdings plc
TIMING OF CHINA JV AGREEMENTS DELAYED UNTIL 2023
Horsham, UK: The Directors of Ceres Power Holdings plc("Ceres", the "Company") (AIM: CWR.L), were informed last night that the negotiations will not conclude this year and approvals for the joint venture (JV) agreements with Robert Bosch GmbH and Weichai Power have been postponed until 2023.
All parties remain committed to the deal, the structure of which has been agreed. There are several commercial items remaining which require more time to be finalised between the partners. Ceres will update the market further on progress as appropriate.
Accordingly, this will delay Ceres' intention to seek a Premium Listing on the Main Market of the London Stock Exchange.
Ends
For further information visitwww.ceres.techor contact:
|
Investec Bank PLC (NOMAD & Joint Broker) James Rudd /Patrick Robb /Ben Griffiths |
Tel: +44 (0)207 597 5970 |
|
|
Berenberg (Joint Broker) Ben Wright / Mark Whitmore |
Tel: +44 (0)203 207 7800 |
|
|
FTI Consulting (Financial PR) Dwight Burden |
Tel: +44 (0)203 727 1000 Email:[email protected] |
|
|
Ceres Power Holdings plc Elizabeth Skerritt |
Tel: +44(0)1403 273 463 |
About Ceres
Ceres is a leading developer of clean energy technology; fuel cells for power generation and electrolysers for green hydrogen. Its licensing model has seen it establish partnerships with some of the world's most progressive companies, such as Bosch, Doosan, Shell and Weichai to develop clean energy systems and products at the scale and pace needed to address climate change for power generation, transportation, industry, and everyday living. Ceres is listed on the AIM market of the London Stock Exchange ("LSE") (AIM: CWR) and is classified by the LSE Green Economy Mark, which recognises listed companies that derive more than 50% of their activity from the green economy.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. ENDJVEGPGWAGUPPPPQ
==